Determination of insulin in innovative formulations by means of LC coupled to fluorescence detection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 5, 2008, Pages 1303-1309

  Mercolini, Laura ^a   Musenga, Alessandro ^a   Saladini, Bruno ^a   Bigucci, Federica ^a   Luppi, Barbara ^a   Zecchi, Vittorio ^a   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Insulin; LC; Microparticles; Nasal inserts; Quality control

Indexed keywords

ACETONITRILE; BOVINE INSULIN; CHITOSAN ADIPATE; CHITOSAN DERIVATIVE; CHITOSAN SUBERATE; CHITOSAN SUCCINATE; HYALURONIC ACID; INSULIN; PHOSPHATE BUFFERED SALINE; POLYELECTROLYTE; SODIUM SULFATE; STEARIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VENLAFAXINE;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG STRUCTURE; ELUTION; EXTRACTION; FLUORESCENCE; FREEZE DRYING; LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PRIORITY JOURNAL; QUALITY CONTROL; VALIDATION STUDY;

ADMINISTRATION, ORAL; BUFFERS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; FLUORESCENCE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; INSULIN; MOLECULAR STRUCTURE; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; PHOSPHATES; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 58149522338     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.09.009     Document Type: Article

References (23)

1. Ludvigsson J. Ann. N. Y. Acad. Sci. 1079 (2006) 374-382
2. Carino G.P., and Mathiowitz E. Adv. Drug Deliv. Rev. 35 (1999) 249-257
3. Richardson T., and Kerr D. Am. J. Clin. Dermatol. 4 (2003) 661-667
4. Hodges G.M., Carr E.A., Hazzard R.A., and Carr K.A. Digest. Dis. Sci. 40 (1995) 967-975
5. Bugamelli F., Raggi M.A., Orienti I., and Zecchi V. Arch. Pharm. 331 (1998) 133-138
6. Rajan D.S., Gowda K.V., Mandal U., Ganesan M., Bose A., Sarkar A.K., and Pal T.K. Indian J. Pharm. Sci. 68 (2006) 662-664
7. Furtado S., Abramson D., Simhkay L., Wobbekind D., and Mathiowitz E. Eur. J. Pharm. Biopharm. 63 (2006) 229-236
8. Yoshioka S., and Aso Y. Yukio. Pharm. Res. 22 (2005) 1358-1364
9. Merisko-Liversidge E., McGurk S.L., and Liversidge G.G. Pharm. Res. 21 (2004) 1545-1553
10. Trenktrog T., and Mueller B.W. Int. J. Pharm. 123 (1995) 199-207
11. Hoffmann J.A., Chance R.E., and Johnson M.G. Protein Expres. Purif. 1 (1990) 127-133
12. Fisher B.V., and Smith D. J. Pharmaceut. Biomed. 4 (1986) 377-387
13. Schrader E., and Pfeiffer E.F. J. Liq. Chromatogr. 8 (1985) 1139-1157
14. Kroeff E.P., and Chance R.E. In: Heller W.M. (Ed). Proceedings of the FDA-USP Workshop on Drug and Reference Standards for Insulins, Somatropins, and Thyroid-axis Hormones (1982), Pharmacopeial Conventions, Inc., Bethesda 148-162
15. Nanami M., Zaitsu K., and Ohkura Y. Biol. Pharm. Bull. 16 (1993) 99-102
16. Yang C., Huang H., Zhang H., and Liu M. Mancang. Anal. Lett. 39 (2006) 2463-2473
17. Liu H.-J., Strong R.E., Krull I.S., and Cohen S.A. Anal. Biochem. 298 (2001) 103-111
18. Toriumi C., and Imai K. Anal. Chem. 74 (2002) 2321-2327
19. Sato J., Kitahara K., Sato T., Inamura T., Kanazawa M., Notoya Y., and Hayashi T. Curr. Ther. Res. 57 (1996) 579-588
20. United States Pharmacopeia, 28th ed., United States Pharmacopeial Convention, Rockville, 2005, pp. 2748-2751.
21. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551-1557
22. Raggi M.A., Nobile L., Bugamelli F., and Mandrioli R. Farmaco 52 (1997) 561-564
23. Brange J., and Langkjaer L. Acta Pharm. Nord. 4 (1992) 149-158